Related Experiment Video
Updated: Aug 4, 2026
07:36
Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
Ephedrine in the cat lung vasculature
A M Fields1, T A Richards, I N Ibrahim
1Department of Anesthesiology and Pharmacology, Texas Tech University School of Medicine, Lubbock, Texas, 79430, USA.
Acta Anaesthesiologica Scandinavica
|August 9, 2003
Summary
Ephedrine significantly increases pulmonary arterial pressure in cats, primarily through alpha1 adrenergic receptors. This study clarifies its mechanism in the feline pulmonary vascular bed.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- Ephedrine is a widely used sympathomimetic agent in clinical settings.
- Its blood pressure-raising effects are crucial for homeostasis and emergencies.
- The specific alpha-adrenergic receptor subtype mediating ephedrine's pulmonary effects was previously unknown.
Purpose of the Study:
- To investigate the role of alpha-adrenergic receptors in mediating ephedrine's effects on the feline pulmonary vasculature.
- To determine the specific alpha-receptor subtype involved in ephedrine-induced pulmonary vasoconstriction.
Main Methods:
- Isolated left lower lobe cat lung preparation with constant blood flow.
- Continuous monitoring and electronic averaging of lobar arterial perfusion pressure.
- Administration of ephedrine, phenylephrine, norepinephrine, and U-46619.
- Assessment of responses after blockade with phentolamine (non-selective alpha-blocker) and prazosin (alpha1-selective blocker).
Main Results:
- Both phentolamine and prazosin significantly attenuated the increases in pulmonary perfusion pressure induced by ephedrine.
- This indicates that ephedrine's vasoconstrictor activity in the pulmonary bed is mediated by alpha-adrenergic receptors.
Conclusions:
- Ephedrine exhibits significant vasopressor activity within the pulmonary vascular bed of the cat.
- This activity is predominantly mediated by the activation of alpha1 adrenergic receptors.
